135 related articles for article (PubMed ID: 20868559)
21. A phase II study of perioperative concurrent chemotherapy, gefitinib, and hyperfractionated radiation followed by maintenance gefitinib in locoregionally advanced esophagus and gastroesophageal junction cancer.
Rodriguez CP; Adelstein DJ; Rice TW; Rybicki LA; Videtic GM; Saxton JP; Murthy SC; Mason DP; Ives DI
J Thorac Oncol; 2010 Feb; 5(2):229-35. PubMed ID: 20009775
[TBL] [Abstract][Full Text] [Related]
22. Chemoradiotherapy of locally advanced esophageal cancer: long-term follow-up of a prospective randomized trial (RTOG 85-01). Radiation Therapy Oncology Group.
Cooper JS; Guo MD; Herskovic A; Macdonald JS; Martenson JA; Al-Sarraf M; Byhardt R; Russell AH; Beitler JJ; Spencer S; Asbell SO; Graham MV; Leichman LL
JAMA; 1999 May; 281(17):1623-7. PubMed ID: 10235156
[TBL] [Abstract][Full Text] [Related]
23. [Feasibility and short-term efficacy of simplified intensity-modulated radiotherapy and concurrent chemotherapy for neck and upper thoracic esophageal carcinoma].
Zhu WG; Yu CH; Han JH; Li T; Zhou XL; Tao GZ
Ai Zheng; 2009 Dec; 28(12):1265-9. PubMed ID: 19958620
[TBL] [Abstract][Full Text] [Related]
24. Combined modality therapy for esophageal carcinoma: preliminary results from a large Australasian multicenter study.
Burmeister BH; Denham JW; O'Brien M; Jamieson GG; Gill PG; Devitt P; Yeoh E; Hamilton CS; Ackland SP; Lamb DS
Int J Radiat Oncol Biol Phys; 1995 Jul; 32(4):997-1006. PubMed ID: 7607974
[TBL] [Abstract][Full Text] [Related]
25. [Prospective non-randomized study of chemotherapy combined with radiotherapy versus chemotherapy alone in patients with metastatic or relapsed esophageal squamous cell carcinoma].
Zhang XD; Shen L; Li J; Li Y; Li J; Zhang XT; Jin ML
Zhonghua Zhong Liu Za Zhi; 2007 Jun; 29(6):474-7. PubMed ID: 17974288
[TBL] [Abstract][Full Text] [Related]
26. Toxicity of chemotherapy for esophageal carcinoma.
Ilson D
Chest Surg Clin N Am; 1997 Aug; 7(3):551-63; discussion 564. PubMed ID: 9246402
[TBL] [Abstract][Full Text] [Related]
27. Chemotherapy rapidly alternating with twice-a-day accelerated radiation therapy in carcinomas involving the hypopharynx or esophagus: an update.
Yu L; Vikram B; Malamud S; Yudelman I; Nussbaum M; Beattie E
Cancer Invest; 1995; 13(6):567-72. PubMed ID: 7583705
[TBL] [Abstract][Full Text] [Related]
28. Concurrent chemoradiotherapy for esophageal cancer: comparison between intermittent standard-dose cisplatin with 5-fluorouracil and daily low-dose cisplatin with continuous infusion of 5-fluorouracil.
Sai H; Mitsumori M; Yamauchi C; Araki N; Okumura S; Nagata Y; Nishimura Y; Hiraoka M
Int J Clin Oncol; 2004 Jun; 9(3):149-53. PubMed ID: 15221597
[TBL] [Abstract][Full Text] [Related]
29. Comparison between continuous accelerated hyperfractionated and late-course accelerated hyperfractionated radiotherapy for esophageal carcinoma.
Wang Y; Shi XH; He SQ; Yao WQ; Wang Y; Guo XM; Wu GD; Zhu LX; Liu TF
Int J Radiat Oncol Biol Phys; 2002 Sep; 54(1):131-6. PubMed ID: 12182982
[TBL] [Abstract][Full Text] [Related]
30. Patterns of failure following combined modality therapy for esophageal cancer, 1984-1990.
Kavanagh B; Anscher M; Leopold K; Deutsch M; Gaydica E; Dodge R; Allen K; Allen D; Staub W; Montana G
Int J Radiat Oncol Biol Phys; 1992; 24(4):633-42. PubMed ID: 1429085
[TBL] [Abstract][Full Text] [Related]
31. The safety and usefulness of high-dose-rate endoluminal brachytherapy as a boost in the treatment of patients with esophageal cancer with external beam radiation with or without chemotherapy.
Vuong T; Szego P; David M; Evans M; Parent J; Mayrand S; Corns R; Burtin P; Faria S; Devic S
Int J Radiat Oncol Biol Phys; 2005 Nov; 63(3):758-64. PubMed ID: 16199311
[TBL] [Abstract][Full Text] [Related]
32. Esophageal preservation--the management of esophageal cancer with concurrent radiation and chemotherapy.
Coia LR
Endoscopy; 1993 Nov; 25(9):664-9. PubMed ID: 8119228
[No Abstract] [Full Text] [Related]
33. Neoadjuvant chemoradiation therapy in patients with surgically treated esophageal cancer.
Vermund H; Pories WJ; Hillard J; Wiley AL; Youngblood R
Acta Oncol; 2001; 40(5):558-65. PubMed ID: 11669326
[TBL] [Abstract][Full Text] [Related]
34. High-dose-rate brachytherapy boost following concurrent chemoradiotherapy for esophageal carcinoma.
Yorozu A; Dokiya T; Oki Y
Int J Radiat Oncol Biol Phys; 1999 Sep; 45(2):271-5. PubMed ID: 10487545
[TBL] [Abstract][Full Text] [Related]
35. Preoperative chemotherapy and radiation for advanced esophageal carcinoma: comparison between once a day radiation and hyperfractionation, a single-institution experience.
Nguyen NP; Leonardo JM; Karlsson U; Salehpour M; Vos P; Robiou C; Moran JF; Thomas P; Bullock L; Ludin A; Jendrasiak G; Sallah S
Am J Clin Oncol; 2002 Aug; 25(4):358-64. PubMed ID: 12151965
[TBL] [Abstract][Full Text] [Related]
36. Phase II study of cisplatin and 5-fluorouracil with concurrent radiotherapy in advanced squamous cell carcinoma of the esophagus: a Japan Esophageal Oncology Group (JEOG)/Japan Clinical Oncology Group trial (JCOG9516).
Ishida K; Ando N; Yamamoto S; Ide H; Shinoda M
Jpn J Clin Oncol; 2004 Oct; 34(10):615-9. PubMed ID: 15591460
[TBL] [Abstract][Full Text] [Related]
37. Chemotherapy and radiation therapy before transhiatal esophagectomy for esophageal carcinoma.
Orringer MB; Forastiere AA; Perez-Tamayo C; Urba S; Takasugi BJ; Bromberg J
Ann Thorac Surg; 1990 Mar; 49(3):348-54; discussion 354-5. PubMed ID: 2106845
[TBL] [Abstract][Full Text] [Related]
38. Late course accelerated hyperfractionated radiotherapy plus concurrent chemotherapy for squamous cell carcinoma of the esophagus: a phase III randomized study.
Zhao KL; Shi XH; Jiang GL; Yao WQ; Guo XM; Wu GD; Zhu LX
Int J Radiat Oncol Biol Phys; 2005 Jul; 62(4):1014-20. PubMed ID: 15990003
[TBL] [Abstract][Full Text] [Related]
39. Efficacy of concurrent chemoradiotherapy as a palliative treatment in stage IVB esophageal cancer patients with dysphagia.
Ikeda E; Kojima T; Kaneko K; Minashi K; Onozawa M; Nihei K; Fuse N; Yano T; Yoshino T; Tahara M; Doi T; Ohtsu A
Jpn J Clin Oncol; 2011 Aug; 41(8):964-72. PubMed ID: 21742654
[TBL] [Abstract][Full Text] [Related]
40. Phase I/II trial of chemoradiotherapy with concurrent S-1 and cisplatin for clinical stage II/III esophageal carcinoma (JCOG 0604).
Tahara M; Fuse N; Mizusawa J; Sato A; Nihei K; Kanato K; Kato K; Yamazaki K; Muro K; Takaishi H; Boku N; Ohtsu A
Cancer Sci; 2015 Oct; 106(10):1414-20. PubMed ID: 26250827
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
